» Articles » PMID: 30890891

The Epidemiology and Pathophysiology of Pseudobulbar Affect and Its Association with Neurodegeneration

Overview
Publisher Dove Medical Press
Date 2019 Mar 21
PMID 30890891
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudobulbar affect is a disorder resulting from neurologic damage manifesting as sudden, stereotyped affective outbursts that are not reflective of internal emotion. A literature review was completed to examine the current understanding of the epidemiology, characterization, diagnosis, pathophysiology, and treatment of pseudobulbar affect. This review revealed that it is common in neurodegenerative disorders but is poorly recognized, placing significant impacts on patients and their families. The disorder appears to result from a disruption of the cortico-limbic-subcortical-thalamic-pontocerebellar network involved in emotional expression and regulation with resulting disruptions of neurotransmitter systems. Effective treatment is available with agents such as selective serotonin reuptake inhibitors and dextromethorphan combined with quinidine, but further well-designed comparative studies are needed. Advances in technology such as neuroimaging may enhance knowledge about the pathophysiology of this disorder, and help guide future interventions.

Citing Articles

Pseudobulbar Affect Among Patients With Dementia.

Charron L, Espiridion E Cureus. 2025; 17(1):e78116.

PMID: 40018468 PMC: 11866213. DOI: 10.7759/cureus.78116.


Suspected Pseudobulbar Affect in Neurodegenerative Disease.

OConnor M, Frank B, DeCaro R, Vives-Rodriguez A, Hurley L, Turk K Int J Geriatr Psychiatry. 2024; 39(10):e70002.

PMID: 39434195 PMC: 11811881. DOI: 10.1002/gps.70002.


Pseudobulbar Affect in an Elderly Female With Small Vessel Ischemic Disease and Alcohol Abuse Disorder: A Case Report.

Safari T, Dehbozorgi M, Laurent B Cureus. 2024; 16(5):e60472.

PMID: 38764710 PMC: 11099384. DOI: 10.7759/cureus.60472.


Emotion Recognition in Multiple System Atrophy: An Exploratory Eye-Tracking Study.

Sidoroff V, Carbone F, Ellmerer P, Bair S, Hoffmann A, Maran T J Mov Disord. 2023; 17(1):38-46.

PMID: 37748924 PMC: 10846972. DOI: 10.14802/jmd.23090.


Definitions, phenomenology, diagnosis, and management of the disorders of laughter and crying in amyotrophic lateral sclerosis (ALS): Consensus from ALS and Motor Neuron Disease Scientific Department of the Brazilian Academy of Neurology.

de Assis Aquino Gondim F, Pinto W, Chieia M, Correia C, Cunha F, Dourado Jr M Arq Neuropsiquiatr. 2023; 81(8):764-775.

PMID: 37647907 PMC: 10468253. DOI: 10.1055/s-0043-1771176.


References
1.
Okuda D, Chyung A, Chin C, Waubant E . Acute pathological laughter. Mov Disord. 2005; 20(10):1389-90. DOI: 10.1002/mds.20607. View

2.
Weintraub D . Therapeutic options for emotional lability: current and emerging treatments. Am J Geriatr Pharmacother. 2005; 3 Suppl A:12-5. DOI: 10.1016/s1543-5946(05)80033-9. View

3.
Newsom-Davis I, Abrahams S, Goldstein L, Leigh P . The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis. J Neurol Sci. 1999; 169(1-2):22-5. DOI: 10.1016/s0022-510x(99)00211-7. View

4.
Paparrigopoulos T, Ferentinos P, Kouzoupis A, Koutsis G, Papadimitriou G . The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour. Int Rev Psychiatry. 2010; 22(1):14-21. DOI: 10.3109/09540261003589323. View

5.
Jagetia A, Kumar N, Singh D, Sinha S . Pathological laughter in trigeminal schwannoma: case report and review of the literature. Neurosurg Rev. 2006; 29(4):348-52. DOI: 10.1007/s10143-006-0038-4. View